Exact Mass: 753.406106
Exact Mass Matches: 753.406106
Found 47 metabolites which its exact mass value is equals to given mass value 753.406106,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Vindesine
Vindesine is only found in individuals that have used or taken this drug. It is a vinblastine derivative with antineoplastic activity against cancer. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (antineoplastic combined chemotherapy protocols). [PubChem]Vindesine acts by causing the arrest of cells in metaphase mitosis through its inhibition tubulin mitotic funcitoning. The drug is cell-cycle specific for the S phase. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01C - Plant alkaloids and other natural products > L01CA - Vinca alkaloids and analogues C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids C1907 - Drug, Natural Product
Desacetylvinblastine amide
Vindesine
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01C - Plant alkaloids and other natural products > L01CA - Vinca alkaloids and analogues D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids
2-[2-[[(1S)-1-carboxylato-5-[[(E)-dec-2-enoyl]-hydroxyamino]pentyl]amino]-2-oxoethyl]-4-[[(1S)-1-carboxylato-5-[hydroxy-[(E)-oct-2-enoyl]amino]pentyl]amino]-2-hydroxy-4-oxobutanoate
C36H57N4O13-3 (753.3921932000001)
1-palmitoyl-2-lauroyl-sn-glycero-3-phospho-1D-myo-inositol(1-)
A phosphatidylinositol 28:0 in which the phosphatidyl acyl groups at positions 1 and 2 are specified as palmitoyl (hexadecanoyl) and lauroyl (dodecanoyl) respectively.
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate
C43H64NO8P (753.4369313999999)
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] (7E,9E,11E,13E,15E,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoate
C43H64NO8P (753.4369313999999)
phosphatidylinositol 28:0(1-)
A 1-phosphatidyl-1D-myo-inositol(1-) in which the acyl groups at C-1 and C-2 contain 28 carbons in total and 0 double bonds.
(2s)-2-({[(2s)-1-[(2s)-2-[(2s)-2-{[(2s,3r)-3-amino-1,2-dihydroxydecylidene]amino}-3-(4-hydroxyphenyl)-n-methylpropanamido]-3-methylpentanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-(4-hydroxyphenyl)propanoic acid
(3r,4s)-4-{[(2r)-2-{[(3r,4s)-1,3-dihydroxy-4-{[(2r)-1-hydroxy-2-{[(2s)-1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-methylbutylidene]amino}-3-methylbutylidene]amino}-5-phenylpentylidene]amino}-1-hydroxypropylidene]amino}-3-hydroxy-5-phenylpentanoic acid
austrospicatine
{"Ingredient_id": "HBIN017386","Ingredient_name": "austrospicatine","Alias": "NA","Ingredient_formula": "C41H55NO12","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C2(C)C)CC1OC(=O)C)C(=C)C(CC3OC(=O)C)OC(=O)C(C(C4=CC=CC=C4)N(C)C)OC(=O)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2024","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-[(2s,5r,8s,11s,14r,17s)-5-(3-aminopropyl)-17-[(2s)-butan-2-yl]-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-11,14-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid
C38H59N9O7 (753.4537224000001)
8-ethyl-1,6,8,11-tetrahydroxy-7-({5-[(5-hydroxy-4,6-dimethyloxan-2-yl)oxy]-n,n,2',6-tetramethyl-[2,3'-bioxan]-4'-yl}oxy)-9,10-dihydro-7h-tetracene-5,12-dione
4-({2-[(1,3-dihydroxy-4-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-methylbutylidene}amino)-3-methylbutylidene]amino}-5-phenylpentylidene)amino]-1-hydroxypropylidene}amino)-3-hydroxy-5-phenylpentanoic acid
3-[9-benzyl-11,14,17,20,23-pentahydroxy-2,8-dioxo-12,18-bis(sec-butyl)-1,7,10,13,16,19,22-heptaazatricyclo[22.3.0.0³,⁷]heptacosa-10,13,16,19,22-pentaen-21-yl]propanoic acid
methyl 9-hydroxy-7-{2-[(9-hydroxy-7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-10-oxo-decahydro-1h-phenanthren-2-yl)oxy]-2-oxoethylidene}-1,4a,8-trimethyl-10-oxo-decahydrophenanthrene-1-carboxylate
3,21',24'-trihydroxy-5,6,11',13'-tetramethyl-4-[(2-methylbutanoyl)oxy]-2'-oxo-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]pentacosane]-10',14',16',22'-tetraen-22'-ylmethyl 1h-pyrrole-2-carboxylate
(1r,3s,9r,10s,13r,15e,17e,19e,21e,23r,25s,26r,27s)-23-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-10,13-diethyl-1,3,9,27-tetrahydroxy-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid
2-[5-(3-aminopropyl)-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-11,14-bis(2-methylpropyl)-17-(sec-butyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid
C38H59N9O7 (753.4537224000001)
methyl (1s,4ar,4bs,7e,8r,8as,9r,10ar)-7-(2-{[(1s,2s,4ar,4bs,7e,8r,8as,9r,10as)-9-hydroxy-7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-10-oxo-decahydro-1h-phenanthren-2-yl]oxy}-2-oxoethylidene)-9-hydroxy-1,4a,8-trimethyl-10-oxo-decahydrophenanthrene-1-carboxylate
2-[(2s,5r,8s,11s,14r,17s)-5-(3-aminopropyl)-17-[(2r)-butan-2-yl]-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-11,14-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid
C38H59N9O7 (753.4537224000001)